Benchmark indices BSE Sensex and NSE Nifty traded snapped their two-day gaining streak on Monday. Sensex fell around  750 points to 57,231 while Nifty 50 sank below 16,900 after erasing the previous session’s gains amid a volatile market. The broader markets traded in the red, the worst loser was Nifty Midcap 50, down 1.74%. Sectorally, all indices followed suit, trading with sharp cuts. Nifty ...

Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19."I'm feeling well and symptom free," Bourla said in a statement.Bourla, 60, back in August had contacted COVID and had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid.Paxlovid is an antiviral medication that is used to treat high-risk people, such as older patients.Bo...

The UK's drug regulator said Saturday it had approved an updated Covid-19 jab by Pfizer/BioNTEch targeting the original virus and a subvariant ahead of an autumn booster drive.The so-called "bivalent" jabs work for both the original virus that emerged in the Chinese city of Wuhan in 2019 and the BA.1 subvariant of Omicron.The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved t...

Indian equity markets are likely to open higher on week’s last trading day. Ahead of Friday’s session, SGX Nifty was up with gains, suggesting a positive opening for benchmark indices BSE Sensex, NSE Nifty 50. Global cues were mixed after Dow Jones and S&P 500 closed with losses while the tech-heavy NASDAQ gained in the US. Asian stock markets were moving higher in morning trade. “Markets wi...

US-Based Pharma major Pfizer’s newly set up global drug development centre in Chennai will play a major role in its plan to introduce 25 therapies internationally by 2025, with a special focus on hospital products and oncology. Over 250 scientists and laboratory technicians involved in pharma research and development are working at the IIT Madras Research Park to develop innovative formulations ...